One of the more narrow-minded approaches to looking at innovation and growth is the argument we live on a planet with finite resources so we have to cut back and retreat to a prelapsarian age.
Month: July 2020
TransferWise carries $5bn valuation
Mitsui and Virgin-backed remittance service TransferWise has bolstered its valuation to $5bn, up from $3.5bn, through a $319m secondary share sale.
Pharmapacks bags $150m investment
GPI Capital and JPMorgan Chase have injected $150m into Pharmapacks, whose backers already include Reckitt Benckiser, McKesson, Sealed Air and Emerson Group.
Jianghang takes off with $148m IPO
Hefei Jianghang Aircraft Equipment has priced its shares at $1.48 each to raise $148m in an initial public offering that provided an exit to Aviation Industry Corporation.
Praxis Precision works out $110m series C1
Novo Holdings returned for a $110m series C1 round for Praxis Precision Medicines, four months after the gene therapy developer emerged from stealth with $100m in funding.
DNA Script rewrites series B
Danaher Life Sciences and Agilent Technology joined existing backers Merck Group and Illumina for a $50m series B extension that increased the round’s total to nearly $89m.
Nice Tuan pleases investors in series C2 round
Alibaba-backed e-commerce company Nice Tuan has raised its third funding round this year, adding $80m to its coffers that now contain almost $300m in total.
Money Forward goes ahead with corporate venturing
The accounting platform operator’s investment subsidiary has unveiled Hirac Fund’s $11.7m initial close with multiple corporate LPs on its way to a $29m ceiling.
Cargo.one’s series A contains $18.6m
Next47 and Lufthansa Cargo were among the investors as air freight booking service Cargo.one looks to pounce on favourable market conditions in the current economic climate.
SmartX accepts $29m
SmartX, a data storage virtualisation business that counts Samsung and Lenovo as shareholders, has announced series B-plus and C funding to expand its product offering.
Code Republic programs eighth cohort
YJ Capital and East Ventures’ joint accelerator scheme has opened the application period for a new batch of innovative startups.
Gentex absorbs Vaporsens
University of Utah spinout Vaporsens has been acquired by Gentex for $10.5m after the corporate had supplied $3m in equity financing.
Indigo Diabetes stabilises $44.5m
Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Ackermans & van Haaren.
Managing change over continuity
Chris O’Donnell’s rapid promotion at Pfizer Ventures, the US-based pharmaceutical firm’s corporate venturing arm, two years after joining as a principal reflects the rapid opportunities for development at the best-run units.